Home › Funds › Patient Square Capital LP › HROW

Patient Square Capital LP position in HROW

HARROW INC · Health Care

Patient Square Capital LP reported holding 145,000 shares of HROW (HARROW INC) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 0.71% of its reported portfolio and ranking #23 among its reported holdings. Patient Square Capital LP has disclosed HROW holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)145.00K sh
Reported value held$4.47M
Portfolio Weight0.71%
First reportedQ4 2025
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's HROW position evolved

Patient Square Capital LP first disclosed a stake in HROW in Q4 2025 at 7,031 shares (US$345K). The position peaked in Q1 2026 at 165,209 shares, worth US$5.8M. Across 3 filings, Patient Square Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 145,000 shares valued at US$4.5M. Notable position changes include a 2250% increase in Q1 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 7.03K $344.52K New
Q1 2026 165.21K $5.83M Add
Q3 2026 145.00K $4.47M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HROW and 13F data

HROW (HARROW INC) is a Health Care company. 34 other funds we track also report a position in HROW — the largest reported positions include Opaleye Management Inc. (US$101.9M), Deep Track Capital, LP (US$41.2M), Divisadero Street Capital Management, LP (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HROW

All HROW fund holders →

FAQ

How long has Patient Square Capital LP held HROW?

Patient Square Capital LP has disclosed HROW holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

What is Patient Square Capital LP's current position in HROW?

As of Q3 2026, Patient Square Capital LP holds 145.00K shares of HROW (HARROW INC), valued at $4.47M, representing 0.71% of its reported portfolio and ranking #23.

Has Patient Square Capital LP been buying or selling HROW?

In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in HROW. The position peaked in Q1 2026 at 165.21K shares.

Which other funds hold HROW?

Other major institutional holders of HROW include Opaleye Management Inc., Deep Track Capital, LP, Divisadero Street Capital Management, LP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.